Debrief · Tue 25 Aug · visit complete

After The Plant Visit

Who
The founder, 80, absentee — and the president, who runs it
Where
Address is in your texts
Phone
In your texts
Via
Warm intro from the referrer

What you actually found

The two men who run the place do not agree on whether there is a problem.

That is worth more than anything you went in looking for. Everything below hangs off it.

The split

Both said this in the same building, within the same hour.

The president, who runs it day to day “No problems really.” Just needs sales, and the play is to chase established companies, not startups.
The founder Business is down, he has been funding it himself, and he does not know why new business is slow.

The founder also said he cannot speak to the other man's ability or capabilities. That is not a neutral sentence.

That line is the most dangerous thing in this file. It never reaches the president, in any form, ever.

Do not take a side, and do not be the one who tells either man what the other said. The moment you become a messenger between them you stop being useful to both.

The contradiction that was not one

This page said the two men disagreed 3x on enquiry volume. Checked against the tape on 26 Aug: they did not.

The founder was asked directly what they get per month. His answer, verbatim:

“we're getting up to it right now — I don't know, I don't think so.”

He then built a worked example to explain the model, and that is where the number came from:

“If you have 15 inquiries in a month and you know what you're doing, the probability … at least 50 percent is higher.”

He never claimed 15 a month as the current volume. He was asked, said he did not know, and reasoned from a hypothetical. He is absentee and says so himself. A conditional got written down as an assertion, and the file carried it for a day as the thing gating everything else.

What actually exists is one soft figure: the president's “ten a week”, from a two-minute recording where the question that preceded it is not on the tape.

Nobody at this company counts enquiries. Or visitors. Or which of the 200 were called. Or purchase orders.

So it is not a demand problem and not a qualification problem. It is a measurement problem, one level below both. Two people describing the same business differently is what a firm with no shared measurement looks like from the inside.

The money

The most important thing the founder said, close to verbatim.

“This month, I know how much I put in here. Just to keep it open. But it's not something I want to continue doing. I don't have the resources anymore.”

Revenue
About $500,000 for the year.
Direction
Trending down since COVID. His words.
His own money
Years of personal injections, nothing back, and he is still doing it this month. He illustrated with two figures then called them hypothetical, so treat the pattern as real and the numbers as unverified.
Books
He does them himself. Nobody else touches them.
Runway
You floated one quarter and the tape is ambiguous about whether he agreed. Do not treat it as agreed. Ask again.

Correction to your first read: “he cannot fund anything” is too strong.

He will not throw good money after bad, and he will not keep funding survival. He will fund something small, concrete and provable that shows a path. He is not expecting you to work for free. A rebuild is not fundable. A couple of thousand for something he can see working is.

The product — and he specified it himself

Unprompted, from the president. This is the single most useful thing anyone said all day.

“Your website has to be made functional. And effective. So you can see the people that click on it, easily Google them, see what company they are, and call them back.”

“Then I can say, oh, I noticed you were looking at our website, is there anything I can do?”

That is visitor identification feeding a calling motion that already exists. It is small, it is buildable, and the client scoped it, not you.

Analytics today
None at all. “Nobody knows who sees it, or who didn't see it.”
Access
They have the website password. This needs access, not paperwork.
Who does it now
Nobody. No sales, marketing, website or outreach person: “I don't think we currently have someone.”
His own words
“If we had leads that we could call, then we would.”

This is not a rebuild for vanity. Do not let it grow into one.

The correction that changes the thesis

Part three of the visit overturned what you believed after part one.

The 200 existing relationships is confirmed. The president named the number himself. But they are not sitting uncontacted. Asked how often he reaches out:

“Go through them at least weekly.”

What he has instead of a system, in his words: “I have a couple different stacks. People that are kind of twiddling their fingers. And the ones that feel like we're getting somewhere with.”

Stacks. Paper or mental. No CRM, no tracking, no sequence.

Kill the “nobody has called them” pitch. He is already doing the work, weekly, with nothing to do it with. The gap is infrastructure, not effort.

Why their new deals die

The president's own reasons, and why they still point somewhere specific.

“Didn't realise it's gonna cost money”
Unfunded.
“I don't have my marketing plan”
Not ready.
No formula
Pays a $500 product development fee to get one. Most never get past it.
Under 2,000 units
Below the MOQ. Dead on arrival, about 20% of enquiries.

His summary: “some of them have dreams and we try to jump in bed with them, but it requires money.”

Now hold that against a former customer. They already have a formula, already know it costs money, already cleared the $500 gate and the 2,000 minimum. Every reason a new enquiry dies is a reason a lapsed customer would not.

His own strategy, unprompted: “get these companies that are already on the shelf, already have a history, and take over their work for them.” His own reality check: “a lot of them are bigger labs.”

Answered on the day

These are closed. Do not ask them again.

MOQ
2,000 units. Anything above that is a fit.
Anything ingestible?
No. No tablets, capsules or powders. Topicals only: creams, lotions, serums. This closes the supplement angle entirely.
OTC
Dropped it. Regulation and cost outweigh the benefit without volume.
Lead time
About three to four weeks.
Terms
50% deposit up front, balance on completion before shipment. Established high-volume buyers can skip the deposit.
Componentry
Client sources it, or they source it at no extra charge.
Best accounts came from
Relationships, testimonials, word of mouth. “Maybe through the website.”
The website
Built by an outside shop. Nobody manages it. He pays annually for domain, hosting and email only.
Who runs the plant
The president, since around 2019 or 2020. The founder is usually not there.
How it closed
“Let's reconnect. Let's see what you come up with.” He is expecting a proposal.

What to do next

  1. Send the thank-you and ask for the date.

    The founder's goes first, and it carries the ask for a morning next week. The joint one to the president follows the same day, with no ask in it. Never the president's alone, and never before the founder's.

  2. Put a date on the coffee in his town.

    He proposed it himself and you agreed, but no date was set. That was the one thing you were not supposed to leave without. It is the whole point of email one.

  3. Ask for the purchase orders, not the enquiries.

    ⛔ Do not re-ask the enquiry count. He already answered it, and he already wondered whether you were competition. Ask instead: “how many purchase orders did you issue in the last twelve months, and what did they total?” One pull, no judgement, and it yields the account count, the average order and the close rate at once.

  4. Scope the small provable build, not the rebuild.

    Visitor identification on the existing site, feeding the calling he already does weekly. Something demonstrable in two weeks. He has no money and no patience for a long build.

  5. Get your collaborator's role and share in writing.

    Before he is on a call with this client, not after. Nothing else on this list is blocked by it, and it gets harder to raise every week it slips.

Do not quote a percentage of his revenue until something has been counted. A fixed fee priced on your own hours is fine now, because that work is what produces the count.

Handle the president first

He read you as a threat in the room. If he goes defensive there is no deal.

His actual question, near the door: “your t-shirt says Labs — are you competition?” Behind it is a fairer worry: a firm arrives to look at efficiency at a struggling company, and the president of that company is the obvious cost to cut.

He must always be the beneficiary, never the audited. He named the product. He does the calling. Anything built here makes his week work better.

No document requests. Asking a man who thinks you might be competition to hand over his files is the exact shape of the thing he is afraid of.

One safe, concrete thing you can raise for free: a departed employee is still on their team page. Obviously true, costs nobody face, and proves you looked.

Never say

Any one of these costs you the room, or the deal.

One thing to watch

The founder asked, unprompted: “years ago you could buy a list of potential customers — how do you do that now?”

You steered him off purchased lists, correctly. But he is still shopping for a lead source. If you do not give him one, somebody will sell him a bad one.

The words, decoded

Reference only. You will be in the room again. Skim when you need it.

What he is

Contract manufacturer
Makes product for other people's brands. That's him.
Private label
His existing formula, client's brand on it. Fast, cheap, low differentiation.
Custom / full-service
Bench work to create something new. Slower, higher margin.
Turnkey
He delivers finished sellable units, components and all.
Tolling
Client supplies the raw material, he only processes. Low margin, keeps a line busy.

The economics

MOQ
Minimum order quantity. 2,000 units here. The gate.
Changeover
Cleaning and resetting a line between products. This is why MOQs exist. If he says it, follow it.
Capacity / line time
Is the plant running full or hungry. Enormous tell.
Bulk
The made product before it goes into containers.
Componentry
Bottles, caps, pumps, closures, cartons. Who buys it moves a lot of margin.

The process, in order

Bench sample
First small lab batch a client tries.
Scale-up
Bench to production batch. Where formulas break.
Batch / lot
One run.
Fill
Bulk into containers, on a fill line.
QC hold / release
Testing gate before it ships.
COA
Certificate of analysis. Ships with the lot.
Stability testing
Sets shelf life. Adds weeks.

Compliance — recognise, never lead with

cGMP
The manufacturing rulebook.
OTC monograph
The rulebook for things like sunscreen and anti-acne. He dropped OTC.
Drug Facts vs Supplement Facts
Which panel is on the label tells you which rulebook applies.
NDC number
Drug product identifier.

Use these only to understand what he makes. Never to probe how he complies.

Pre-visit material

Kept for the record. Both are superseded by everything above.